Document text
Principal Investigator: Joseph J Eron
Organization: UNIV OF NORTH CAROLINA CHAPEL HILL
Fiscal Year: 2020
Award: $600,000
Funding agency: National Institute of Allergy and Infectious Diseases
Project Summary/Abstract
The University of North Carolina (UNC) Global HIV Clinical Trials Unit (CTU) has a well
established track record of high-quality, innovative clinical research, strong scientific leadership
(both in and outside the NIH HIV/AIDS Networks), and access to critically important infected and
at-risk populations in the Southeastern US, Southeast Asia and in Southern Africa. Drawn from
a diverse team of clinical innvestigators spanning two continents, our is led by experienced
principal investigators (Joseph Eron MD and Mina Hosseinipour MD) and will support all 5 NIH
HIV Clinical Trials Networks: Adult Therapeutic Strategies, Strategies to Address HIV and HIV-
associated Infections in Pediatric and Maternal Populations, Integrated HIV Prevention
Strategies, Microbicide Strategies, and Vaccine Strategies to Prevent HIV Infection. The Clinical
Research Sites (CRS) include Chapel Hill CRS led by David Wohl MD (Adult Therapeutic
Strategies, Integrated Prevention, Microbicide and Vaccine), Greensboro CRS led by Cornelius
Van Dam MD PhD (Adult Therapeutic Strategy and Integrated Prevention), Malawi CRS led by
Lameck Chinula MD (all 5 Networks) and Vietnam (protocol specific site) led by Vivian Go.
Supporting this leadership is a well-organized research team, comprising global experts and site
collaborators who will work to execute the network scientific agendas. The CTU has also
assembled a diverse group of senior scientists and public health officials to serve on our
Scientific and Strategic Advisory Group. The CTU administration incorporates a highly
organized structure that will be responsive to our experienced research teams across the CRS
and will provide ongoing evaluation to ensure optimal performance and efficiency. The CTU is
supported by state-of-the-art communications and outstanding laboratory, pharmacy, quality
assurance, data management and regulatory support. With its robust administrative framework,
the UNC Global HIV CTU is optimally positioned to provide scientific leadership and clinical
trials infrastructure to advance the field of agenda of the NIAID HIV networks and emerging
infectious disease such as the SARS-CoV-2 pandemic.
Terms: <2019 novel coronavirus><2019-nCoV><21+ years old><AIDS Virus><AIDS prevention><AIDS/HIV><AIDS/HIV problem><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Adherence><Adult><Adult Human><Agriculture><Area><Back><Belgium><COVID-19><COVID-19 epidemic><COVID-19 pandemic><COVID19><COVID19 epidemic><COVID19 pandemic><Caring><Cessation of life><Childhood><China><Clinic><Clinical><Clinical Research><Clinical Study><Clinical Trials><Clinical Trials Network><Clinical Trials Unit><Color><Communicable Disease Contact Tracing><Communication><Communities><Contact Tracing><Containment><Coronaviridae><Coronavirus><Country><County><Data><Death><Detection><Diagnosis><Diagnostic><Disease><Disease Outbreaks><Disorder><Doctor of Philosophy><Dorsum><Emerging Communicable Diseases><Emerging Infectious Diseases><Ensure><Equipment><Evaluation><Farm><Farming environment><Finland><Formosa><General Population><General Public><Geography><Germany><Goals><HIV><HIV Infections><HIV Prevention><HIV/AIDS><HIV/AIDS prevention><HIV/AIDS problem><HTLV-III Infections><HTLV-III-LAV Infections><Health><Healthcare><Home><Home environment><Hospital Admission><Hospitalization><Human><Human Immunodeficiency Viruses><Human T-Lymphotropic Virus Type III Infections><Incidence><Individual><Industry><Infection><Infection Control><Infectious Disease Contact Tracing><Infrastructure><Institutes><LAV-HTLV-III><Laboratories><Leadership><Life><Living Standards><Lymphadenopathy-Associated Virus><Mainland China><Malawi><Meat><Modeling><Modern Man><Molecular><NIAID><NIH><National Institute of Allergy and Infectious Disease><National Institutes of Health><North Carolina><Nyasaland><Outbreaks><Performance><Ph.D.><PhD><Pharmacies><Pharmacy facility><Planets><Plants><Play><Population><Populations at Risk><Position><Positioning Attribute><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Principal Investigator><Protocol><Protocols documentation><Public Health><Quarantine><Reporting><Republic of China><Republic of Korea><Research><Research Resources><Resources><Role><Rural><SARS-CoV-2><SARS-CoV2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><Senior Scientist><Severe acute respiratory syndrome coronavirus 2><Site><Social Distance><South Korea><Southeast Asia><Southeastern Asia><Southern Africa><Structure><Taiwan><Tennessee><Testing><Therapeutic><Time><Transmission><Unemployment><United States National Institutes of Health><Universities><Vaccines><Viet Nam><Vietnam><Virus><Virus-HIV><Work><Wuhan coronavirus><adulthood><agricultural><authority><clinical research site><clinical site><corona virus><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><coronavirus disease 2019><coronavirus disease 2019 epidemic><coronavirus disease 2019 pandemic><data management><experience><farm environment><global health><health care><improved><innovate><innovation><innovative><isolation/quarantine><jobless><joblessness><microbicidal><microbicide><operation><out of work><pandemic><pandemic disease><pediatric><preservation><prevent><preventing><quality assurance><racial and ethnic disparities><response><rural area><rural counties><rural region><screening><social role><transmission process><unemployed><urban area>